Debiopharm is a venture capital fund that invests in early-stage companies, focusing on privacy, security, data, and business intelligence. They have supported companies like Tune Insight. Debiopharm bridges the gap between discovery and patient reach, specializing in oncology and bacterial infections. They develop prescription drugs and collaborate with larger pharmaceutical companies to ensure global patient access. For early-stage research in molecules seeking further development, contact Debiopharm.
